{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:57:50Z","timestamp":1778770670775,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.lungcan.2018.09.012","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T13:06:45Z","timestamp":1537189605000},"page":"157-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer"],"prefix":"10.1016","volume":"125","author":[{"given":"Dijana","family":"Djureinovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2875-896X","authenticated-orcid":false,"given":"Tea","family":"Dodig-Crnkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Holgersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bergqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna S.M.","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Pont\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"St\u00e5hle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8141-8449","authenticated-orcid":false,"given":"Jochen M.","family":"Schwenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Micke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2018.09.012_bib0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2017.06.033","article-title":"PD-1\/PD-L1 checkpoint blockades in non-small cell lung cancer: new development and challenges","volume":"405","author":"Meng","year":"2017","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.lungcan.2018.09.012_bib0010","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1158\/1078-0432.CCR-14-1187","article-title":"Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer","volume":"21","author":"Anagnostou","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.lungcan.2018.09.012_bib0015","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1158\/1078-0432.CCR-16-0049","article-title":"Emerging opportunities and challenges in Cancer immunotherapy","volume":"22","author":"Whiteside","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2018.09.012_bib0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.canlet.2017.11.014","article-title":"Progress and challenges of predictive biomarkers of anti PD-1\/PD-L1 immunotherapy: a systematic review","volume":"414","author":"Teng","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lungcan.2018.09.012_bib0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2016.12.039","article-title":"MHC class II restricted neoantigen: a promising target in tumor immunotherapy","volume":"392","author":"Sun","year":"2017","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.lungcan.2018.09.012_bib0030","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1200\/JCO.2017.75.3384","article-title":"Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-Cell lung Cancer Profiled with targeted next-generation sequencing","volume":"36","author":"Rizvi","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2018.09.012_bib0035","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","article-title":"Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers","volume":"16","author":"Goodman","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"10","key":"10.1016\/j.lungcan.2018.09.012_bib0040","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86837","article-title":"Profiling cancer testis antigens in non\u2013small-cell lung cancer","volume":"1","author":"Djureinovic","year":"2016","journal-title":"JCI Insight"},{"issue":"18","key":"10.1016\/j.lungcan.2018.09.012_bib0045","doi-asserted-by":"crossref","first-page":"15772","DOI":"10.18632\/oncotarget.4694","article-title":"Oncogenic cancer\/testis antigens: prime candidates for immunotherapy","volume":"6","author":"Gjerstorff","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.lungcan.2018.09.012_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0169-5002(03)00244-7","article-title":"Expression of cancer\/testis (CT) antigens in lung cancer","volume":"42","author":"Tajima","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2018.09.012_bib0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1034\/j.1600-065X.2002.18803.x","article-title":"Cancer\/testis antigens: an expanding family of targets for cancer immunotherapy","volume":"188","author":"Scanlan","year":"2002","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.lungcan.2018.09.012_bib0060","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6","article-title":"Humoral immune responses of cancer patients against \"Cancer-Testis\" antigen NY-ESO-1: correlation with clinical events","volume":"84","author":"Jager","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.lungcan.2018.09.012_bib0065","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00262-008-0478-5","article-title":"Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient","volume":"57","author":"Tsuji","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.lungcan.2018.09.012_bib0070","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1470-2045(16)00099-1","article-title":"Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"Vansteenkiste","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2018.09.012_bib0075","doi-asserted-by":"crossref","first-page":"8840","DOI":"10.1038\/ncomms9840","article-title":"Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer","volume":"6","author":"Maxfield","year":"2015","journal-title":"Nat. Commun."},{"issue":"54","key":"10.1016\/j.lungcan.2018.09.012_bib0080","doi-asserted-by":"crossref","first-page":"92966","DOI":"10.18632\/oncotarget.21715","article-title":"Genome-wide identification of cancer\/testis genes and their association with prognosis in a pan-cancer analysis","volume":"8","author":"da Silva","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.lungcan.2018.09.012_bib0085","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.18632\/oncotarget.2802","article-title":"Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets","volume":"6","author":"Mirandola","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.lungcan.2018.09.012_bib0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canlet.2012.08.019","article-title":"A cancer\/testis antigen microarray to screen autoantibody biomarkers of non-small cell lung cancer","volume":"328","author":"Shan","year":"2013","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.lungcan.2018.09.012_bib0095","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.lungcan.2015.07.012","article-title":"Humoral immune responses of lung cancer patients against the Transmembrane Phosphatase with TEnsin homology (TPTE)","volume":"90","author":"Kuemmel","year":"2015","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2018.09.012_bib0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jtho.2016.09.136","article-title":"Case-control study: smoking history affects the production of tumor antigen-specific antibodies NY-ESO-1 in patients with lung Cancer in comparison with Cancer disease-Free group","volume":"12","author":"Mysikova","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2018.09.012_bib0105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/path.2440","article-title":"The human protein atlas--a tool for pathology","volume":"216","author":"Ponten","year":"2008","journal-title":"J. Pathol."},{"issue":"17","key":"10.1016\/j.lungcan.2018.09.012_bib0110","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1002\/pmic.200500072","article-title":"Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling","volume":"5","author":"Nilsson","year":"2005","journal-title":"Proteomics"},{"issue":"9","key":"10.1016\/j.lungcan.2018.09.012_bib0115","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1074\/mcp.M112.026757","article-title":"Autoantibody profiling in multiple sclerosis using arrays of human protein fragments","volume":"12","author":"Ayoglu","year":"2013","journal-title":"Mol. Cell Proteomics"},{"issue":"6","key":"10.1016\/j.lungcan.2018.09.012_bib0120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/08916934.2016.1183655","article-title":"Autoantibody targets in vaccine-associated narcolepsy","volume":"49","author":"Haggmark-Manberg","year":"2016","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.lungcan.2018.09.012_bib0125","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1021\/acs.jproteome.6b00916","article-title":"Whole-proteome peptide microarrays for profiling autoantibody repertoires within multiple sclerosis and narcolepsy","volume":"16","author":"Zandian","year":"2017","journal-title":"J. Proteome Res."},{"issue":"5","key":"10.1016\/j.lungcan.2018.09.012_bib0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/08830185.2012.723512","article-title":"Cancer testis antigens: a novel target in lung cancer","volume":"31","author":"Chiriva-Internati","year":"2012","journal-title":"Int. Rev. Immunol."},{"issue":"16","key":"10.1016\/j.lungcan.2018.09.012_bib0135","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1158\/0008-5472.CAN-15-0248","article-title":"An autoimmune response signature associated with the development of triple-negative breast Cancer Reflects disease pathogenesis","volume":"75","author":"Katayama","year":"2015","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.lungcan.2018.09.012_bib0140","first-page":"427","article-title":"Screening for multiple autoantibodies in plasma of patients with breast Cancer","volume":"14","author":"Bassaro","year":"2017","journal-title":"Cancer Genomics Proteomics"},{"issue":"13","key":"10.1016\/j.lungcan.2018.09.012_bib0145","doi-asserted-by":"crossref","first-page":"16420","DOI":"10.18632\/oncotarget.7500","article-title":"Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.lungcan.2018.09.012_bib0150","doi-asserted-by":"crossref","first-page":"11151","DOI":"10.18632\/oncotarget.7098","article-title":"A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection","volume":"7","author":"Dumstrei","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.lungcan.2018.09.012_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147739","article-title":"Serum autoantibodies in chronic prostate inflammation in prostate Cancer patients","volume":"11","author":"Schlick","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.lungcan.2018.09.012_bib0160","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pros.21444","article-title":"Serum-autoantibodies for discovery of prostate cancer specific biomarkers","volume":"72","author":"Massoner","year":"2012","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.lungcan.2018.09.012_bib0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/acs.jproteome.6b00559","article-title":"Serum protein markers for the early detection of lung Cancer: a focus on autoantibodies","volume":"16","author":"Broodman","year":"2017","journal-title":"J. Proteome Res."},{"issue":"2","key":"10.1016\/j.lungcan.2018.09.012_bib0170","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/annonc\/mdq361","article-title":"Clinical validation of an autoantibody test for lung cancer","volume":"22","author":"Boyle","year":"2011","journal-title":"Ann. Oncol."},{"issue":"31","key":"10.1016\/j.lungcan.2018.09.012_bib0175","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1200\/JCO.2008.16.2388","article-title":"Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera","volume":"26","author":"Qiu","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2018.09.012_bib0180","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.lungcan.2016.07.018","article-title":"Autoantibodies against tumor-associated antigens in the early detection of lung cancer","volume":"99","author":"Dai","year":"2016","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2018.09.012_bib0185","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s13277-012-0379-2","article-title":"EarlyCDT(R)-Lung test: improved clinical utility through additional autoantibody assays","volume":"33","author":"Chapman","year":"2012","journal-title":"Tumour Biol."},{"issue":"1-2","key":"10.1016\/j.lungcan.2018.09.012_bib0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jim.2008.10.016","article-title":"Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays","volume":"341","author":"Gnjatic","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.lungcan.2018.09.012_bib0195","first-page":"207","article-title":"Serological analysis of expression cDNA libraries (SEREX): an immunoscreening technique for identifying immunogenic tumor antigens","volume":"103","author":"Chen","year":"2005","journal-title":"Methods Mol. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2018.09.012_bib0200","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/acs.jproteome.6b00620","article-title":"Identification of a novel autoimmune peptide epitope of prostein in prostate Cancer","volume":"16","author":"Pin","year":"2017","journal-title":"J. Proteome Res."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218305713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218305713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T21:29:41Z","timestamp":1540502981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500218305713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":40,"alternative-id":["S0169500218305713"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.09.012","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}